Investing28d
BTIG sustains Buy rating on HUMA shares amid FDA form 483
On Friday, BTIG reaffirmed its Buy rating and $10.00 stock price target for Humacyte (NASDAQ:HUMA) following the release of a Form 483 from the FDA. The form, which details findings from facility ...
Business Standard15d
Shilpa Medicare slips after US FDA issues four form 483 obersvations to Bengaluru facility
The inspection concluded with the issuance of Form 483 with four observations ... The site has already been approved by MHRA-UK and TGA Australia and has US FDA approval for supplying nutraceutical ...
Daily1d
Cipla gets 8 USFDA observations for Virgonagar facility
Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the ...
Andhra Sugars aspirin unit passes US FDA check
Vijayawada: The Andhra Sugars Limited has undergone US FDA inspection at their aspirin manufacturing facility at ...
FDA lifts hold on North Carolina drug factory one year after maggots found
The U.S. Food and Drug Administration has lifted a clinical hold on three cell therapies being developed by CARsgen ...
ndtvprofit2d
Cipla Gets Eight Observations After FDA Inspection
The FDA conducted an inspection at the manufacturing facility in Virgonagar from Nov. 7 to Nov. 13, according to an exchange ...
Daily11d
Shilpa Medicare gets four USFDA observations for Bengaluru facility
Raichur: Shilpa Medicare has announced that the US Food and Drug Administration (USFDA) has issued Form 483 with four ...